← Back to Search

Procedure

Guidewire IV Catheters for Catheter Survival

N/A

Recruiting

Led By Amit Bahl, MD

Research Sponsored by William Beaumont Hospitals

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Study participants must be ≥ 18 years old with a Vascular Access Score of 4 or 5

Be older than 18 years old

Must not have

Study participants must be <18 years old

Study participants must not be cognitively impaired

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 30 days post discharge

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if an IV catheter with a built-in guide wire is better than one without it for catheter failure.

Who is the study for?

This trial is for clinicians at Corewell Health William Beaumont University Hospital who are trained in vascular access and patients over 18 with a specific Vascular Access Score. Patients must be able to give consent, have no cognitive impairments, skin issues at the IV site, or limited elbow mobility.

What is being tested?

The study compares two types of intravenous catheters: one standard ultralong catheter and another with a built-in guide wire. Participants will be randomly assigned to either group to see if the guide wire improves catheter longevity without increasing complications.

What are the potential side effects?

Potential side effects may include discomfort at the insertion site, infection, phlebitis (vein inflammation), or other complications related to peripheral intravenous access.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older with a high need for vascular access.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am younger than 18 years old.

Select...

I do not have any cognitive impairments.

Select...

I can move my elbow joint freely.

Select...

My skin is clear for IV access.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ first day of hospitalization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~first day of hospitalization

This trial's timeline: 3 weeks for screening, Varies for treatment, and first day of hospitalization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

First-stick success rate

Survival of the BBraun 6.35 centimeter 20 gauge ultralong intravenous catheter compared to the BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire

Time to insertion

Secondary study objectives

Catheter Associated Thrombosis

Catheter Associated bloodstream infection

Cost for all vascular needs during hospitalization